Education
About Us
Working with TipRanks
Follow Us
Creative Medical Technology Holdings (CELZ)
NASDAQ:CELZ
RESEARCH TOOLSreports
Total Valuation
Creative Medical Technology Holdings has a market cap or net worth of $5.17M. The enterprise value is ―.
Market Cap$5.17M
Enterprise Value―
Share Statistics
Creative Medical Technology Holdings has 2,585,532 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,585,532
Owned by Insiders0.01%
Owned by Institutions5.72%
Financial Efficiency
Creative Medical Technology Holdings’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -90.58%.
Return on Equity (ROE)-0.87
Return on Assets (ROA)-0.82
Return on Invested Capital (ROIC)-90.58%
Return on Capital Employed (ROCE)-0.91
Revenue Per Employee2.75K
Profits Per Employee-1.37M
Employee Count4
Asset Turnover<0.01
Inventory Turnover2.01
Valuation Ratios
The current PE Ratio of Creative Medical Technology Holdings is -0.62. Creative Medical Technology Holdings’s PEG ratio is >-0.01.
PE Ratio-0.62
PS Ratio0.00
PB Ratio0.53
Price to Fair Value0.54
Price to FCF-1.09
Price to Operating Cash Flow-0.63
PEG Ratio>-0.01
Income Statement
In the last 12 months, Creative Medical Technology Holdings had revenue of 11.00K and earned -5.49M in profits. Earnings per share was -3.71.
Revenue11.00K
Gross Profit6.60K
Operating Income-5.74M
Pretax Income-5.49M
Net Income-5.49M
EBITDA-5.63M
Earnings Per Share (EPS)-3.71
Cash Flow
In the last 12 months, operating cash flow was -5.30M and capital expenditures 0.00, giving a free cash flow of -5.30M billion.
Operating Cash Flow-5.30M
Free Cash Flow-5.30M
Free Cash Flow per Share-2.05
Dividends & Yields
Creative Medical Technology Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change-55.45%
50-Day Moving Average2.20
200-Day Moving Average3.03
Relative Strength Index (RSI)42.02
Average Volume (3m)66.98K
Important Dates
Creative Medical Technology Holdings upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Creative Medical Technology Holdings as a current ratio of 18.73, with Debt / Equity ratio of 0.00%
Current Ratio18.73
Quick Ratio18.72
Debt to Market Cap0.00
Net Debt to EBITDA1.05
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Creative Medical Technology Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Creative Medical Technology Holdings EV to EBITDA ratio is 0.45, with an EV/FCF ratio of 0.48.
EV to Sales-229.15
EV to EBITDA0.45
EV to Free Cash Flow0.48
EV to Operating Cash Flow0.48
Balance Sheet
Creative Medical Technology Holdings has $5.94M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$5.94M billion.
Cash & Marketable Securities$5.94M
Total Debt$0.00
Net Cash-$5.94M
Net Cash Per Share-$2.30
Tangible Book Value Per Share$3.93
Margins
Gross margin is -472.20%, with operating margin of -52216.92%, and net profit margin of -49940.74%.
Gross Margin-472.20%
Operating Margin-52216.92%
Pretax Margin-49940.74%
Net Profit Margin-49940.74%
EBITDA Margin-51212.81%
EBIT Margin-52216.92%
Analyst Forecast
The average price target for Creative Medical Technology Holdings is $26.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$26.00
Price Target Upside1213.13% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―